OTC Pharmaceuticals - Madagascar

  • Madagascar
  • Revenue in the OTC Pharmaceuticals market amounts to US$40.15m in 2024. The market is expected to grow annually by 10.49% (CAGR 2024-2029).
  • The market's largest segment is the segment Vitamins & Minerals with a market volume of US$13.52m in 2024.
  • In global comparison, most revenue is generated in the United States (US$41,240m in 2024).
  • In relation to total population figures, per person revenues of US$1.29 are generated in 2024.
  • In the OTC Pharmaceuticals market, 2.3% of total revenue will be generated through online sales by 2024.

Key regions: Worldwide, India, Philippines, United States, Europe

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The OTC Pharmaceuticals market in Madagascar is experiencing steady growth due to increasing customer preferences for self-medication and the availability of a wide range of over-the-counter products. This market is driven by several trends, including the growing demand for convenience and affordability, the expansion of retail pharmacies, and the rising awareness of preventive healthcare.

Customer preferences in the OTC Pharmaceuticals market in Madagascar are shifting towards self-medication. Consumers are increasingly seeking products that can be purchased without a prescription, allowing them to treat common ailments and minor health issues on their own. This preference for self-care is driven by factors such as convenience, cost-effectiveness, and the desire to avoid unnecessary visits to healthcare professionals.

Another trend in the market is the expansion of retail pharmacies. As the number of retail pharmacies increases, consumers have greater access to a wide range of OTC products. This trend is supported by the growing urbanization in Madagascar, which has led to the establishment of more pharmacies in urban areas.

The presence of retail pharmacies not only provides consumers with easy access to OTC medications but also allows them to seek advice from trained pharmacists. The rising awareness of preventive healthcare is also contributing to the growth of the OTC Pharmaceuticals market in Madagascar. Consumers are becoming more proactive in managing their health and are seeking products that can help prevent illnesses and maintain overall well-being.

This trend is driven by factors such as increasing health consciousness, the availability of information through digital platforms, and the promotion of preventive healthcare by healthcare professionals and organizations. In addition to these customer preferences, there are local special circumstances that are shaping the OTC Pharmaceuticals market in Madagascar. The country's healthcare system is characterized by limited access to healthcare facilities, particularly in rural areas.

This lack of access to healthcare services drives the demand for OTC medications, as consumers rely on self-medication to address their healthcare needs. Furthermore, the high prevalence of infectious diseases in Madagascar, such as malaria and dengue fever, creates a need for OTC products that can help manage the symptoms of these diseases. Underlying macroeconomic factors also play a role in the development of the OTC Pharmaceuticals market in Madagascar.

The country's economic growth and increasing disposable income levels have contributed to the affordability of OTC medications for a larger portion of the population. Additionally, the government's efforts to improve healthcare infrastructure and promote access to essential medicines have created a favorable environment for the growth of the OTC Pharmaceuticals market. Overall, the OTC Pharmaceuticals market in Madagascar is experiencing growth due to customer preferences for self-medication, the expansion of retail pharmacies, the rising awareness of preventive healthcare, local special circumstances, and underlying macroeconomic factors.

As these trends continue to shape the market, the demand for OTC medications is expected to further increase in the coming years.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Key Players
  • Analyst Opinion
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)